The Medical Device Contract Manufacturing Market Is Projected To Grow At An Annualized Rate Of 8%

By Author: Roots Analysis
Total Articles: 43
Comment this article

Roots Analysis has done a detailed study on Medical Device Contract Manufacturing Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 590+ page report, which features 275+ figures and 290+ tables, please visit this link

Key Market Insights
 Over 270 companies worldwide have the necessary expertise and authorization to offer contract manufacturing services for various types of medical devices, including therapeutic and diagnostic products
 The market landscape is fragmented, featuring the presence of both established players and new entrants; presently, most medical device manufacturing facilities are located in the developed geographies
 Medical device CMOs are actively engaged in aligning their operations to comply to the standards established by various global and regional regulatory bodies
 Companies involved in this domain are steadily expanding their capabilities in order to enhance their respective service portfolios and comply to evolving industry benchmarks
 In the last ...
... six years, over 9,600 trials evaluating various medical devices have been registered by different types of sponsors covering a wide range of therapeutic areas
 Implants have emerged as one of the most prominent segments for which the acquisition activity is relatively higher; key value drivers behind such acquisitions include capability addition and geographical consolidation
 Driven by a rapidly growing demand, medical device contract services market is anticipated to grow at annualized rate of 8% for a variety of therapeutic areas and geographies for finished products
 Established CMOs currently occupy a major share; in the long term, the opportunity is anticipated to be better distributed across different types of companies, device classes and application areas

For more information, please visit https://www.rootsanalysis.com/reports/view_document/medical-device-contract-manufacturing-market-2019-2030/258.html

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Medical Devices: An Overview
3.2.1. History of Medical Devices
3.2.2. Classification of Medical Devices
3.3. Medical Device Manufacturing
3.3.1. Challenges Associated with Medical Device Manufacturing
3.3.2. Role of CMOs in Medical Device Manufacturing
3.3.3. Role of Automation in Medical Device Manufacturing Process
3.4. Historical Timeline for Medical Device CMOs
3.5. Services Offered by Medical Device CMOs
3.6. Advantages Offered by Medical Device CMOs
3.7. Risks associated with Outsourcing to CMOs
3.8. Key Considerations
3.9. Concluding Remarks

4. REGULATORY LANDSCAPE FOR MEDICAL DEVICES
4.1. Chapter Overview
4.2. General Regulatory Guidelines for Medical Devices

4.3. Regulatory Landscape in North America
4.3.1. The US Scenario
4.3.1.1. Regulatory Authority
4.3.1.2. Review / Approval Process
4.3.2. The Canadian Scenario
4.3.2.1. Regulatory Authority
4.3.2.2. Review / Approval Process

4.4. Regulatory Landscape in Europe
4.4.1. Overall Scenario
4.4.1.1. Regulatory Authority
4.4.1.2. Review / Approval Process
4.4.2. Case Study: Brexit -The UK Scenario

4.5. Regulatory Landscape in Asia-Pacific
4.5.1. The Chinese Scenario
4.5.1.1. Regulatory Authority
4.5.1.2. Review / Approval Process
4.5.2. The Japanese Scenario
4.5.2.1. Regulatory Authority
4.5.2.2. Review / Approval Process
4.5.3. The Australian Scenario
4.5.3.1. Regulatory Authority
4.5.3.2. Review / Approval Process

4.6. Comparison of Regional Regulatory Environment

5. MARKET OVERVIEW: THERAPEUTIC DEVICES
5.1. Chapter Overview
5.2. Medical Device CMOs Offering Services for Therapeutic Devices
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Size of Employee Base
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Location of Manufacturing Facility
5.2.5. Analysis by Regulatory Certifications / Accreditations
5.2.6. Analysis by Production Services Offered
5.2.7. Analysis by Post-production Services Offered
5.2.8. Analysis by Other Services Offered
5.2.9. Analysis by Device Class
5.2.10. Analysis by Type of Material(s) Handled
5.2.11. Analysis by Scale of Operation
5.2.12. Leading Players

6. MARKET OVERVIEW: DIAGNOSTIC DEVICES
6.1. Chapter Overview
6.2. Medical Device CMOs Offering Services for Diagnostic Devices
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Size of Employee Base
6.2.3. Analysis by Location of Headquarters
6.2.4. Analysis by Location of Manufacturing Facility
6.2.5. Analysis by Regulatory Certifications / Accreditations
6.2.6. Analysis by Production Services Offered
6.2.7. Analysis by Post-Production Services Offered
6.2.8. Analysis by Other Services Offered
6.2.9. Analysis by Device Class
6.2.10. Analysis by Type of Material(s) Handled
6.2.11. Analysis by Scale of Operation
6.2.12. Leading Players

7. MARKET OVERVIEW: DELIVERY SYSTEMS AND OTHERS
7.1. Chapter Overview
7.2. Catheters
7.2.1. Medical Device CMOs Offering Services for Catheters
7.2.2. Analysis by Year of Establishment
7.2.3. Analysis by Size of Employee Base
7.2.4. Analysis by Location of Headquarters
7.2.5. Analysis by Location of Manufacturing Facility
7.2.6. Analysis by Regulatory Certifications / Accreditations
7.2.7. Analysis by Production Services Offered
7.2.8. Analysis by Post-Production Services Offered
7.2.9. Analysis by Other Services Offered
7.2.10. Analysis by Device Class
7.2.11. Analysis by Type of Material(s) Handled
7.2.12. Analysis by Scale of Operation
7.2.13. Leading Players

7.3. Drug Delivery Devices
7.3.1. Medical Device CMOs Offering Services for Drug Delivery Devices
7.3.2. Analysis by Year of Establishment
7.3.3. Analysis by Size of Employee Base
7.3.4. Analysis by Location of Headquarters
7.3.5. Analysis by Location of Manufacturing Facility
7.3.6. Analysis by Regulatory Certifications / Accreditations
7.3.7. Analysis by Production Services Offered
7.3.8. Analysis by Post-Production Services Offered
7.3.9. Analysis by Other Services Offered
7.3.10. Analysis by Device Class
7.3.11. Analysis by Type of Material(s) Handled
7.3.12. Analysis by Scale of Operation
7.3.13. Leading Players

7.4. Other Devices
7.4.1. Medical Device CMOs Offering Services for Other Medical Devices
7.4.2. Analysis by Year of Establishment
7.4.3. Analysis by Size of Employee Base
7.4.4. Analysis by Location of Headquarters
7.4.5. Analysis by Location of Manufacturing Facility
7.4.6. Analysis by Regulatory Certifications / Accreditations
7.4.7. Analysis by Production Services Offered
7.4.8. Analysis by Post-Production Services Offered
7.4.9. Analysis by Other Services Offered
7.4.10. Analysis by Device Class
7.4.11. Analysis by Type of Material(s) Handled
7.4.12. Analysis by Scale of Operation

8. BENCHMARK ANALYSIS
8.1. Chapter Overview
8.2. Benchmark Analysis: Methodology

8.3. Region-wise Benchmark Analysis
8.3.1. North America, Peer Group I
8.3.2. North America, Peer Group II
8.3.3. North America, Peer Group III
8.3.4. North America, Peer Group IV
8.3.5. North America, Peer Group V
8.3.6. North America, Peer Group VI
8.3.7. North America, Peer Group VII
8.3.8. Europe, Peer Group VIII
8.3.9. Europe, Peer Group IX
8.3.10. Europe, Peer Group X
8.3.11. Asia, Peer Group XI
8.3.12. Asia, Peer Group XII
8.4. Concluding Remarks

9. SUPPLY CHAIN ANALYSIS
9.1. Chapter Overview
9.2. Overview of the Medical Device Supply Chain
9.3. Factors Affecting the Medical Device Supply Chain
9.4. Key Performance Indicators

9.5. Supply Chain Improvement Strategies
9.5.1. Optimization of Supply Chain Capabilities
9.5.2. Visible Supply Chain and Related Advantages
9.5.2.1. Augmenting Supply Chain Visibility Through Digitalization
9.5.2.2. Benefits of Digital Supply Chain

9.6. Effects of Supply Chain Optimization

9.7. Cost Analysis
9.7.1. Production-related Costs
9.7.1.1. Labor Costs
9.7.1.2. Raw Materials Related Costs
9.7.1.3. Regulatory Compliance
9.7.1.4. Technology-related Costs
9.7.2. Supply Chain-related Costs
9.7.2.1. Local Presence
9.7.2.2. Geopolitical Risk
9.7.2.3. Logistics

10. COMPANY PROFILES
10.1. Chapter Overview
10.2. CMOs Headquartered in North America
10.2.1. Cirtec Medical
10.2.1.1. Company Overview
10.2.1.2. Service Portfolio
10.2.1.3. Manufacturing Capabilities and Facilities
10.2.1.3.1. Facilities located in North America
10.2.1.3.2. Facilities Located in Europe
10.2.1.4. Future Outlook

10.2.2. DynaFlex Technologies
10.2.2.1. Company Overview
10.2.2.2. Service Portfolio
10.2.2.3. Manufacturing Capabilities and Facilities
10.2.2.4. Future Outlook

10.2.3. I-Tek Medical Technologies
10.2.3.1. Company Overview
10.2.3.2. Service Portfolio
10.2.3.3. Manufacturing Capabilities and Facilities
10.2.3.4. Future Outlook

10.2.4. Keystone Solutions Group
10.2.4.1. Company Overview
10.2.4.2. Service portfolio
10.2.4.3. Manufacturing Facilities
10.2.4.4. Future Outlook

10.2.5. Oscor
10.2.5.1. Company Overview
10.2.5.2. Service Portfolio
10.2.5.3. Manufacturing Capabilities and facilities
10.2.5.4. Future Outlook

10.2.6. SMC
10.2.6.1. Company Overview
10.2.6.2. Service Portfolio
10.2.6.3. Manufacturing Capabilities and facilities
10.2.6.3.1. Facilities Located in North America
10.2.6.3.2. Facility Located in Central America
10.2.6.3.3. Facility Located in Europe
10.2.6.3.4. Facility Located in Asia
10.2.6.4. Future Outlook

10.2.7. Stellartech Research
10.2.7.1. Company Overview
10.2.7.2. Service Portfolio
10.2.7.3. Manufacturing Capabilities and facilities
10.2.7.4. Future Outlook

10.3. CMOs Headquartered in Europe
10.3.1. Creganna Medical
10.3.1.1. Company Overview
10.3.1.2. Service Portfolio
10.3.1.3. Manufacturing Facilities
10.3.1.3.1. Facilities Located in North America
10.3.1.3.2. Facilities Located in Central America
10.3.1.3.3. Facilities Located in Europe
10.3.1.3.4. Facilities Located in Asia
10.3.1.4. Future Outlook

10.3.2. Europlaz Technologies
10.3.2.1. Company Overview
10.3.2.2. Service Portfolio
10.3.2.3. Manufacturing facilities
10.3.2.4. Future Outlook

10.3.3. Riverside Medical Packaging
10.3.3.1. Company Overview
10.3.3.2. Service Portfolio
10.3.3.3. Manufacturing Facilities
10.3.3.4. Future Outlook

10.3.4. Synecco
10.3.4.1. Company Overview
10.3.4.2. Service Portfolio
10.3.4.3. Manufacturing Facilities
10.3.4.3.1. Facilities Located in Europe
10.3.4.3.2. Facilities Located in Asia
10.3.4.4. Future Outlook

10.3.5. Trelleborg Sealing Solutions
10.3.5.1. Company Overview
10.3.5.2. Service Portfolio
10.3.5.3. Manufacturing Facilities
10.3.5.3.1. Facilities Located in North America
10.3.5.3.2. Facilities Located in Europe
10.3.5.4. Future Outlook

10.4. CMOs Headquartered in Asia
10.4.1. Interplex
10.4.1.1. Company Overview
10.4.1.2. Service Portfolio
10.4.1.3. Manufacturing Facilities
10.4.1.3.1. Facilities Located in North America
10.4.1.3.2. Facilities Located in Europe
10.4.1.3.3. Facilities Located in Asia
10.4.1.4. Future Outlook

10.4.2. Modern Medical
10.4.2.1. Company Overview
10.4.2.2. Service Portfolio
10.4.2.3. Manufacturing facilities
10.4.2.4. Future Outlook
10.4.3. Providence Enterprise
10.4.3.1. Company Overview
10.4.3.2. Service Portfolio
10.4.3.3. Manufacturing Facilities
10.4.3.4. Future Outlook

10.4.4. Suzhou Jenitek
10.4.4.1. Company overview
10.4.4.2. Service Portfolio
10.4.4.3. Manufacturing Facilities
10.4.4.4. Future Outlook

11. CLINICAL TRIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Clinical Trial Analysis: Word Cloud of Trial Titles

11.4. Analysis of Clinical Trials
11.4.1. Analysis by Trial Start Year
11.4.2. Analysis by Trial Status
11.4.3. Analysis by Phase of Development
11.4.4. Analysis by Target Indication
11.4.5. Analysis by Type of Sponsor
11.4.6. Analysis by Geography
11.4.7. Analysis by Trial Start Year and Geography

11.5. Analysis of Enrolled Patient Population
11.5.1. Analysis by Trial Status
11.5.2. Analysis by Phase of Development
11.5.3. Analysis by Geography

11.6. Analysis of Focus Therapeutic Areas
11.6.1. Analysis by Type of Sponsor
11.6.2. Analysis by Geography
11.6.2.1. North American Scenario
11.6.2.2. European Scenario
11.6.2.3. Asia Pacific Scenario
11.6.2.4. Rest of the World Scenario

11.6.3. Cardiovascular Disorders
11.6.3.1. Analysis by Trial Start Year
11.6.3.2. Analysis by Type of Sponsor
11.6.3.3. Analysis by Geography

11.6.4. Oncological Disorders
11.6.4.1. Analysis by Trial Start Year
11.6.4.2. Analysis by Type of Sponsor
11.6.4.3. Analysis by Geography

11.6.5. Central Nervous System (CNS) Disorders
11.6.5.1. Analysis by Trial Start Year
11.6.5.2. Analysis by Type of Sponsor
11.6.5.3. Analysis by Geography

11.6.6. Orthopedic Disorders
11.6.6.1. Analysis by Trial Start Year
11.6.6.2. Analysis by Type of Sponsor
11.6.6.3. Analysis by Geography

11.6.7. Respiratory Disorders
11.6.7.1. Analysis by Trial Start Year
11.6.7.2. Analysis by Type of Sponsor
11.6.7.3. Analysis by Geography

12. MERGERS AND ACQUISITIONS
12.1. Chapter Overview
12.2. Merger and Acquisition Models
12.3. Medical Device Contract Manufacturing: Mergers and Acquisitions
12.3.1. Analysis by Year of Mergers and Acquisitions
12.3.2. Analysis by Type of Acquisition
12.3.3. Most Active Acquirers: Analysis by Number of Acquisitions
12.3.4. Analysis by Key Value Drivers
12.3.4.1. Continent-wise distribution
12.3.4.2. Intercontinental and Intracontinental Deals
12.3.4.3. Country-wise distribution

12.3.5. Ownership Change Matrix
12.3.6. Acquisitions Made by Medical Device Companies
12.3.6.1. Acquisition of Entire Company
12.3.6.1.1. Analysis by Key Value Drivers
12.3.6.1.2. Analysis by Key Value Drivers and Year of Acquisition
12.3.6.1.3. Analysis by Type of Services Offered
12.3.6.1.4. Analysis by Type of Device
12.3.6.1.5. Analysis by Therapeutic Area
12.3.6.2. Acquisition of Company Assets
12.3.6.2.1. Analysis by Key Value Drivers
12.3.6.2.2. Analysis by Key Value Drivers and Year of Acquisition

12.3.7. Acquisition by Private Equity Firms
12.3.7.1. Analysis by Year of Acquisition
12.3.7.2. Analysis by Type of Acquisition
12.3.7.3. Analysis by Type of Device
12.3.7.4. Analysis by Therapeutic Area

12.4. Key Acquisitions: Deal Multiples
12.4.1. Analysis by Revenues

13. CASE STUDY: OFFSHORING MEDICAL DEVICE CONTRACT MANUFACTURING
13.1. Chapter Overview
13.2. Emerging Markets: Definitions and Key Regions
13.3. Role of Emerging Markets in Industrial Manufacturing
13.3.1. Contributions to the Automobile Industry
13.3.2. Contributions to the Aerospace and Defense Industries
13.4. Medical Devices Manufacturing in Emerging Markets
13.4.1. The US-Chinese Scenario
13.4.2. Partnership with Companies in Emerging Markets

13.5. Multinational Companies Focused on Manufacturing Medical Devices in Emerging Markets

13.6. Business Models for Medical Device Manufacturing in Emerging Markets
13.6.1. Case Studies
13.6.1.1. Study A: Overview
13.6.1.1.1. Value Proposition
13.6.1.1.2. Value Creation
13.6.1.2. Study B: Overview
13.6.1.2.1. Value Proposition
13.6.1.2.2. Value Creation

13.7. Key Challenges related to Innovation in the Medical Device Industry
13.7.1. Limitations of In-House Innovation
13.8. Advantages of Establishing Innovation Hubs in Emerging Markets
13.8.1. Challenges and Market Restraints
13.8.2. Strategies to Address Existing Challenges
13.9. Future Perspectives

14. MARKET FORECAST
14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions

14.3. Overall Medical Device Contract Manufacturing Market, 2019-2030
14.3.1. Medical Device Contract Manufacturing Market: Distribution by Application Areas, 2019, 2025 and 2030
14.3.1.1. Medical Device Contract Manufacturing Market for Therapeutic Devices, 2019- 2030
14.3.1.2. Medical Device Contract Manufacturing Market for Diagnostic Devices, 2019- 2030
14.3.1.3. Medical Device Contract Manufacturing Market for Drug Delivery Devices, 2019- 2030
14.3.1.4. Medical Device Contract Manufacturing Market for Other Devices, 2019-2030

14.3.2. Medical Device Contract Manufacturing Market: Distribution by Device Class, 2019 and 2030
14.3.2.1. Medical Device Contract Manufacturing Market: Class I Devices, 2019-2030
14.3.2.2. Medical Device Contract Manufacturing Market: Class II Devices, 2019-2030
14.3.2.3. Medical Device Contract Manufacturing Market: Class III Devices, 2019-2030

14.3.3. Medical Device Contract Manufacturing Market: Leading Players, 2019-2030

14.3.4. Medical Device Contract Manufacturing Market: Distribution by Therapeutic Areas, 2019 and 2030
14.3.4.1. Medical Device Contract Manufacturing Market for Cardiovascular Disorders, 2019-2030
14.3.4.2. Medical Device Contract Manufacturing Market for CNS Disorders, 2019-2030
14.3.4.3. Medical Device Contract Manufacturing Market for Metabolic Disorders, 2019- 2030
14.3.4.4. Medical Device Contract Manufacturing Market for Oncological Disorders, 2019- 2030
14.3.4.5. Medical Device Contract Manufacturing Market for Orthopedic Disorders, 2019- 2030
14.3.4.6. Medical Device Contract Manufacturing Market for Ophthalmic Disorders, 2019- 2030
14.3.4.7. Medical Device Contract Manufacturing Market for Pain Disorders, 2019-2030
14.3.4.8. Medical Device Contract Manufacturing Market for Respiratory Disorders, 2019- 2030
14.3.4.9. Medical Device Contract Manufacturing Market for Other Therapeutic Areas, 2019-2030

14.4. Medical Device Contract Manufacturing Market: Distribution by Geography, 2019, 2025 and 2030
14.4.1. Medical Device Contract Manufacturing Market in North America, 2019-2030
14.4.1.1. Medical Device Contract Manufacturing Market in the US, 2019-2030
14.4.1.2. Medical Device Contract Manufacturing Market in Rest of North America, 2019- 2030
14.4.1.3. Medical Device Contract Manufacturing Market in North America: Class I Devices, 2019-2030
14.4.1.4. Medical Device Contract Manufacturing Market in North America: Class II Devices, 2019-2030
14.4.1.5. Medical Device Contract Manufacturing Market in North America: Class III Devices, 2019-2030
14.4.1.6. Medical Device Contract Manufacturing Market in North America for Cardiovascular Disorders, 2019-2030
14.4.1.7. Medical Device Contract Manufacturing Market in North America for CNS Disorders, 2019-2030
14.4.1.8. Medical Device Contract Manufacturing Market in North America for Metabolic Disorders, 2019-2030
14.4.1.9. Medical Device Contract Manufacturing Market in North America for Oncological Disorders, 2019-2030
14.4.1.10. Medical Device Contract Manufacturing Market in North America for Orthopedic Disorders, 2019-2030
14.4.1.11. Medical Device Contract Manufacturing Market in North America for Ophthalmic Disorders, 2019-2030
14.4.1.12. Medical Device Contract Manufacturing Market in North America for Pain Disorders, 2019-2030
14.4.1.13. Medical Device Contract Manufacturing Market in North America for Respiratory Disorders, 2019-2030
14.4.1.14. Medical Device Contract Manufacturing Market for Other Therapeutic Areas in North America, 2019-2030

14.4.2. Medical Device Contract Manufacturing Market in Europe, 2019-2030
14.4.2.1. Medical Device Contract Manufacturing Market in Italy, 2019-2030
14.4.2.2. Medical Device Contract Manufacturing Market in Germany, 2019-2030
14.4.2.3. Medical Device Contract Manufacturing Market in France, 2019-2030
14.4.2.4. Medical Device Contract Manufacturing Market in Spain, 2019-2030
14.4.2.5. Medical Device Contract Manufacturing Market in the UK, 2019-2030
14.4.2.6. Medical Device Contract Manufacturing Market in Rest of Europe, 2019-2030
14.4.2.7. Medical Device Contract Manufacturing Market in Europe: Class I Devices, 2019- 2030
14.4.2.8. Medical Device Contract Manufacturing Market in Europe: Class II Devices, 2019-2030
14.4.2.9. Medical Device Contract Manufacturing Market in Europe: Class III Devices, 2019-2030
14.4.2.10. Medical Device Contract Manufacturing Market in Europe for Cardiovascular Disorders, 2019-2030
14.4.2.11. Medical Device Contract Manufacturing Market in Europe for CNS Disorders, 2019-2030
14.4.2.12. Medical Device Contract Manufacturing Market in Europe for Metabolic Disorders, 2019-2030
14.4.2.13. Medical Device Contract Manufacturing Market in Europe for Oncological Disorders, 2019-2030
14.4.2.14. Medical Device Contract Manufacturing Market in Europe for Orthopedic Disorders, 2019-2030
14.4.2.15. Medical Device Contract Manufacturing Market in Europe for Ophthalmic Disorders, 2019-2030
14.4.2.16. Medical Device Contract Manufacturing Market in Europe for Pain Disorders, 2019-2030
14.4.2.17. Medical Device Contract Manufacturing Market in Europe for Respiratory Disorders, 2019-2030
14.4.2.18. Medical Device Contract Manufacturing Market in Europe for Other Therapeutic Areas, 2019-2030

14.4.3. Medical Device Contract Manufacturing Market in Asia Pacific, 2019-2030
14.4.3.1. Medical Device Contract Manufacturing Market in China, 2019-2030
14.4.3.2. Medical Device Contract Manufacturing Market in Japan, 2019-2030
14.4.3.3. Medical Device Contract Manufacturing Market in India, 2019-2030
14.4.3.4. Medical Device Contract Manufacturing Market in Rest of Asia Pacific, 2019- 2030
14.4.3.5. Medical Device Contract Manufacturing Market in Asia Pacific: Class I Devices, 2019-2030
14.4.3.6. Medical Device Contract Manufacturing Market in Asia Pacific: Class II Devices, 2019-2030
14.4.3.7. Medical Device Contract Manufacturing Market in Asia Pacific: Class III Devices, 2019-2030
14.4.3.8. Medical Device Contract Manufacturing Market in Asia Pacific for Cardiovascular Disorders, 2019-2030
14.4.3.9. Medical Device Contract Manufacturing Market in Asia Pacific for CNS Disorders, 2019-2030
14.4.3.10. Medical Device Contract Manufacturing Market in Asia Pacific for Metabolic Disorders, 2019-2030
14.4.3.11. Medical Device Contract Manufacturing Market in Asia Pacific for Oncological Disorders, 2019-2030
14.4.3.12. Medical Device Contract Manufacturing Market in Asia Pacific for Orthopedic Disorders, 2019-2030
14.4.3.13. Medical Device Contract Manufacturing Market in Asia Pacific for Ophthalmic Disorders, 2019-2030
14.4.3.14. Medical Device Contract Manufacturing Market in Asia Pacific for Pain Disorders, 2019-2030
14.4.3.15. Medical Device Contract Manufacturing Market in Asia Pacific for Respiratory Disorders, 2019-2030
14.4.3.16. Medical Device Contract Manufacturing Market in Asia Pacific for Other Therapeutic Areas, 2019-2030

14.4.4. Medical Device Contract Manufacturing Market in Rest of the World, 2019-2030
14.4.4.1. Medical Device Contract Manufacturing Market in Rest of the World: Class I Devices, 2019-2030
14.4.4.2. Medical Device Contract Manufacturing Market in Rest of the World: Class II Devices, 2019-2030
14.4.4.3. Medical Device Contract Manufacturing Market in Rest of the World: Class III Devices, 2019-2030
14.4.4.4. Medical Device Contract Manufacturing Market in Rest of the World for Cardiovascular Disorders, 2019-2030
14.4.4.5. Medical Device Contract Manufacturing Market in Rest of the World for CNS Disorders, 2019-2030
14.4.4.6. Medical Device Contract Manufacturing Market in Rest of the World for Metabolic Disorders, 2019-2030
14.4.4.7. Medical Device Contract Manufacturing Market in Rest of the World for Oncological Disorders, 2019-2030
14.4.4.8. Medical Device Contract Manufacturing Market in Rest of the World for Orthopedic Disorders, 2019-2030
14.4.4.9. Medical Device Contract Manufacturing Market in Rest of the World for Ophthalmic Disorders, 2019-2030
14.4.4.10. Medical Device Contract Manufacturing Market in Rest of the World for Pain Disorders, 2019-2030
14.4.4.11. Medical Device Contract Manufacturing Market in Rest of the World for Respiratory Disorders, 2019-2030
14.4.4.12. Medical Device Contract Manufacturing Market in Rest of the World for Other Therapeutic Areas, 2019-2030

15. SWOT ANALYSIS
15.1. Chapter Overview
15.2. Strengths
15.3. Weaknesses
15.4. Opportunities
15.5. Threats
15.6. Concluding Remarks

16. CONCLUSION
16.1. Chapter Overview
16.2. Key Takeaways

17. SURVEY / INTERVIEW TRANSCRIPTS

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com